nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C19—Rosuvastatin—atherosclerosis	0.0794	0.112	CbGbCtD
Formoterol—CYP2C19—Simvastatin—atherosclerosis	0.0739	0.104	CbGbCtD
Formoterol—CYP2C19—Lovastatin—atherosclerosis	0.0723	0.102	CbGbCtD
Formoterol—CYP2D6—Niacin—atherosclerosis	0.071	0.1	CbGbCtD
Formoterol—CYP2C9—Rosuvastatin—atherosclerosis	0.0661	0.093	CbGbCtD
Formoterol—CYP2C9—Simvastatin—atherosclerosis	0.0614	0.0865	CbGbCtD
Formoterol—CYP2C9—Pravastatin—atherosclerosis	0.0601	0.0846	CbGbCtD
Formoterol—CYP2C9—Lovastatin—atherosclerosis	0.0601	0.0846	CbGbCtD
Formoterol—CYP2D6—Simvastatin—atherosclerosis	0.0562	0.0791	CbGbCtD
Formoterol—CYP2D6—Pravastatin—atherosclerosis	0.0549	0.0774	CbGbCtD
Formoterol—CYP2D6—Lovastatin—atherosclerosis	0.0549	0.0774	CbGbCtD
Formoterol—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000954	0.00396	CcSEcCtD
Formoterol—Urinary tract infection—Lovastatin—atherosclerosis	0.000951	0.00395	CcSEcCtD
Formoterol—Influenza—Niacin—atherosclerosis	0.000943	0.00391	CcSEcCtD
Formoterol—Influenza—Pravastatin—atherosclerosis	0.000928	0.00385	CcSEcCtD
Formoterol—Arrhythmia—Rosuvastatin—atherosclerosis	0.000926	0.00384	CcSEcCtD
Formoterol—Angina pectoris—Niacin—atherosclerosis	0.000918	0.00381	CcSEcCtD
Formoterol—Sinusitis—Lovastatin—atherosclerosis	0.000918	0.00381	CcSEcCtD
Formoterol—Mental disorder—Rosuvastatin—atherosclerosis	0.000908	0.00377	CcSEcCtD
Formoterol—Bronchitis—Niacin—atherosclerosis	0.000907	0.00376	CcSEcCtD
Formoterol—Angina pectoris—Pravastatin—atherosclerosis	0.000904	0.00375	CcSEcCtD
Formoterol—Sinusitis—Ezetimibe—atherosclerosis	0.000901	0.00374	CcSEcCtD
Formoterol—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000863	0.00358	CcSEcCtD
Formoterol—Sinusitis—Simvastatin—atherosclerosis	0.000859	0.00356	CcSEcCtD
Formoterol—Pharyngitis—Ezetimibe—atherosclerosis	0.000855	0.00355	CcSEcCtD
Formoterol—Oedema peripheral—Ezetimibe—atherosclerosis	0.000849	0.00352	CcSEcCtD
Formoterol—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000847	0.00351	CcSEcCtD
Formoterol—Angioedema—Rosuvastatin—atherosclerosis	0.000825	0.00342	CcSEcCtD
Formoterol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000816	0.00339	CcSEcCtD
Formoterol—Myocardial infarction—Pravastatin—atherosclerosis	0.000811	0.00337	CcSEcCtD
Formoterol—Urinary tract infection—Pravastatin—atherosclerosis	0.000804	0.00334	CcSEcCtD
Formoterol—Cough—Rosuvastatin—atherosclerosis	0.000787	0.00327	CcSEcCtD
Formoterol—Immune system disorder—Ezetimibe—atherosclerosis	0.000778	0.00323	CcSEcCtD
Formoterol—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000777	0.00322	CcSEcCtD
Formoterol—Sinusitis—Pravastatin—atherosclerosis	0.000776	0.00322	CcSEcCtD
Formoterol—Arthralgia—Rosuvastatin—atherosclerosis	0.000768	0.00319	CcSEcCtD
Formoterol—Myalgia—Rosuvastatin—atherosclerosis	0.000768	0.00319	CcSEcCtD
Formoterol—Rhinitis—Niacin—atherosclerosis	0.000756	0.00314	CcSEcCtD
Formoterol—Mental disorder—Ezetimibe—atherosclerosis	0.000755	0.00313	CcSEcCtD
Formoterol—Malnutrition—Ezetimibe—atherosclerosis	0.00075	0.00311	CcSEcCtD
Formoterol—Dysgeusia—Lovastatin—atherosclerosis	0.000749	0.00311	CcSEcCtD
Formoterol—Rhinitis—Pravastatin—atherosclerosis	0.000745	0.00309	CcSEcCtD
Formoterol—Oedema peripheral—Niacin—atherosclerosis	0.000743	0.00308	CcSEcCtD
Formoterol—Back pain—Lovastatin—atherosclerosis	0.00074	0.00307	CcSEcCtD
Formoterol—Pharyngitis—Pravastatin—atherosclerosis	0.000737	0.00306	CcSEcCtD
Formoterol—Muscle spasms—Lovastatin—atherosclerosis	0.000735	0.00305	CcSEcCtD
Formoterol—Infection—Rosuvastatin—atherosclerosis	0.000732	0.00304	CcSEcCtD
Formoterol—Visual impairment—Niacin—atherosclerosis	0.000727	0.00302	CcSEcCtD
Formoterol—Back pain—Ezetimibe—atherosclerosis	0.000726	0.00301	CcSEcCtD
Formoterol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000722	0.003	CcSEcCtD
Formoterol—Muscle spasms—Ezetimibe—atherosclerosis	0.000721	0.00299	CcSEcCtD
Formoterol—Mental disorder—Simvastatin—atherosclerosis	0.00072	0.00299	CcSEcCtD
Formoterol—Tremor—Lovastatin—atherosclerosis	0.000716	0.00297	CcSEcCtD
Formoterol—Visual impairment—Pravastatin—atherosclerosis	0.000716	0.00297	CcSEcCtD
Formoterol—Ill-defined disorder—Lovastatin—atherosclerosis	0.00071	0.00294	CcSEcCtD
Formoterol—Dysgeusia—Simvastatin—atherosclerosis	0.0007	0.00291	CcSEcCtD
Formoterol—Angioedema—Lovastatin—atherosclerosis	0.000699	0.0029	CcSEcCtD
Formoterol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000696	0.00289	CcSEcCtD
Formoterol—Malaise—Lovastatin—atherosclerosis	0.00069	0.00286	CcSEcCtD
Formoterol—Cardiac disorder—Pravastatin—atherosclerosis	0.000689	0.00286	CcSEcCtD
Formoterol—Muscle spasms—Simvastatin—atherosclerosis	0.000688	0.00285	CcSEcCtD
Formoterol—Angioedema—Ezetimibe—atherosclerosis	0.000685	0.00284	CcSEcCtD
Formoterol—Malaise—Ezetimibe—atherosclerosis	0.000676	0.00281	CcSEcCtD
Formoterol—Arrhythmia—Niacin—atherosclerosis	0.000674	0.0028	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000671	0.00278	CcSEcCtD
Formoterol—Tremor—Simvastatin—atherosclerosis	0.00067	0.00278	CcSEcCtD
Formoterol—Insomnia—Rosuvastatin—atherosclerosis	0.000666	0.00276	CcSEcCtD
Formoterol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000664	0.00275	CcSEcCtD
Formoterol—Arrhythmia—Pravastatin—atherosclerosis	0.000664	0.00275	CcSEcCtD
Formoterol—Palpitations—Ezetimibe—atherosclerosis	0.000663	0.00275	CcSEcCtD
Formoterol—Malnutrition—Niacin—atherosclerosis	0.000657	0.00273	CcSEcCtD
Formoterol—Cough—Ezetimibe—atherosclerosis	0.000655	0.00272	CcSEcCtD
Formoterol—Angioedema—Simvastatin—atherosclerosis	0.000654	0.00271	CcSEcCtD
Formoterol—Chest pain—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Formoterol—Myalgia—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Formoterol—Arthralgia—Lovastatin—atherosclerosis	0.000651	0.0027	CcSEcCtD
Formoterol—Anxiety—Lovastatin—atherosclerosis	0.000649	0.00269	CcSEcCtD
Formoterol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000648	0.00269	CcSEcCtD
Formoterol—Hypertension—Ezetimibe—atherosclerosis	0.000648	0.00269	CcSEcCtD
Formoterol—Malaise—Simvastatin—atherosclerosis	0.000645	0.00268	CcSEcCtD
Formoterol—Tension—Niacin—atherosclerosis	0.000645	0.00267	CcSEcCtD
Formoterol—Discomfort—Lovastatin—atherosclerosis	0.000643	0.00267	CcSEcCtD
Formoterol—Myalgia—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Formoterol—Arthralgia—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Formoterol—Chest pain—Ezetimibe—atherosclerosis	0.000639	0.00265	CcSEcCtD
Formoterol—Nervousness—Niacin—atherosclerosis	0.000638	0.00265	CcSEcCtD
Formoterol—Dry mouth—Lovastatin—atherosclerosis	0.000637	0.00264	CcSEcCtD
Formoterol—Tension—Pravastatin—atherosclerosis	0.000635	0.00263	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000634	0.00263	CcSEcCtD
Formoterol—Dysgeusia—Pravastatin—atherosclerosis	0.000633	0.00263	CcSEcCtD
Formoterol—Muscle spasms—Niacin—atherosclerosis	0.000631	0.00262	CcSEcCtD
Formoterol—Discomfort—Ezetimibe—atherosclerosis	0.000631	0.00262	CcSEcCtD
Formoterol—Constipation—Rosuvastatin—atherosclerosis	0.00063	0.00261	CcSEcCtD
Formoterol—Pain—Rosuvastatin—atherosclerosis	0.00063	0.00261	CcSEcCtD
Formoterol—Nervousness—Pravastatin—atherosclerosis	0.000628	0.00261	CcSEcCtD
Formoterol—Dry mouth—Ezetimibe—atherosclerosis	0.000625	0.00259	CcSEcCtD
Formoterol—Anaphylactic shock—Lovastatin—atherosclerosis	0.000624	0.00259	CcSEcCtD
Formoterol—Muscle spasms—Pravastatin—atherosclerosis	0.000622	0.00258	CcSEcCtD
Formoterol—Infection—Lovastatin—atherosclerosis	0.00062	0.00257	CcSEcCtD
Formoterol—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000612	0.00254	CcSEcCtD
Formoterol—Arthralgia—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Formoterol—Chest pain—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Formoterol—Myalgia—Simvastatin—atherosclerosis	0.000609	0.00253	CcSEcCtD
Formoterol—Infection—Ezetimibe—atherosclerosis	0.000608	0.00252	CcSEcCtD
Formoterol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000607	0.00252	CcSEcCtD
Formoterol—Anxiety—Simvastatin—atherosclerosis	0.000607	0.00252	CcSEcCtD
Formoterol—Tremor—Pravastatin—atherosclerosis	0.000606	0.00251	CcSEcCtD
Formoterol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000602	0.0025	CcSEcCtD
Formoterol—Discomfort—Simvastatin—atherosclerosis	0.000602	0.0025	CcSEcCtD
Formoterol—Nervous system disorder—Ezetimibe—atherosclerosis	0.0006	0.00249	CcSEcCtD
Formoterol—Angioedema—Niacin—atherosclerosis	0.0006	0.00249	CcSEcCtD
Formoterol—Ill-defined disorder—Pravastatin—atherosclerosis	0.0006	0.00249	CcSEcCtD
Formoterol—Skin disorder—Ezetimibe—atherosclerosis	0.000595	0.00247	CcSEcCtD
Formoterol—Angioedema—Pravastatin—atherosclerosis	0.000591	0.00245	CcSEcCtD
Formoterol—Urticaria—Rosuvastatin—atherosclerosis	0.000585	0.00243	CcSEcCtD
Formoterol—Anaphylactic shock—Simvastatin—atherosclerosis	0.000584	0.00242	CcSEcCtD
Formoterol—Oedema—Simvastatin—atherosclerosis	0.000584	0.00242	CcSEcCtD
Formoterol—Malaise—Pravastatin—atherosclerosis	0.000583	0.00242	CcSEcCtD
Formoterol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000582	0.00242	CcSEcCtD
Formoterol—Palpitations—Niacin—atherosclerosis	0.00058	0.00241	CcSEcCtD
Formoterol—Infection—Simvastatin—atherosclerosis	0.00058	0.00241	CcSEcCtD
Formoterol—Cough—Niacin—atherosclerosis	0.000573	0.00238	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000569	0.00236	CcSEcCtD
Formoterol—Insomnia—Lovastatin—atherosclerosis	0.000565	0.00234	CcSEcCtD
Formoterol—Cough—Pravastatin—atherosclerosis	0.000564	0.00234	CcSEcCtD
Formoterol—Arthralgia—Niacin—atherosclerosis	0.000559	0.00232	CcSEcCtD
Formoterol—Myalgia—Niacin—atherosclerosis	0.000559	0.00232	CcSEcCtD
Formoterol—Hypertension—Pravastatin—atherosclerosis	0.000558	0.00232	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000558	0.00231	CcSEcCtD
Formoterol—Dyspnoea—Lovastatin—atherosclerosis	0.000556	0.00231	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000555	0.0023	CcSEcCtD
Formoterol—Insomnia—Ezetimibe—atherosclerosis	0.000554	0.0023	CcSEcCtD
Formoterol—Arthralgia—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Formoterol—Chest pain—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Formoterol—Myalgia—Pravastatin—atherosclerosis	0.000551	0.00228	CcSEcCtD
Formoterol—Dyspepsia—Lovastatin—atherosclerosis	0.000549	0.00228	CcSEcCtD
Formoterol—Anxiety—Pravastatin—atherosclerosis	0.000549	0.00228	CcSEcCtD
Formoterol—Dry mouth—Niacin—atherosclerosis	0.000547	0.00227	CcSEcCtD
Formoterol—Dyspnoea—Ezetimibe—atherosclerosis	0.000546	0.00226	CcSEcCtD
Formoterol—Discomfort—Pravastatin—atherosclerosis	0.000544	0.00226	CcSEcCtD
Formoterol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000543	0.00225	CcSEcCtD
Formoterol—Dyspepsia—Ezetimibe—atherosclerosis	0.000539	0.00224	CcSEcCtD
Formoterol—Fatigue—Lovastatin—atherosclerosis	0.000538	0.00223	CcSEcCtD
Formoterol—Anaphylactic shock—Niacin—atherosclerosis	0.000536	0.00222	CcSEcCtD
Formoterol—Oedema—Niacin—atherosclerosis	0.000536	0.00222	CcSEcCtD
Formoterol—Pain—Lovastatin—atherosclerosis	0.000534	0.00221	CcSEcCtD
Formoterol—Constipation—Lovastatin—atherosclerosis	0.000534	0.00221	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000532	0.00221	CcSEcCtD
Formoterol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000529	0.00219	CcSEcCtD
Formoterol—Asthenia—Rosuvastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Formoterol—Insomnia—Simvastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Formoterol—Anaphylactic shock—Pravastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Formoterol—Oedema—Pravastatin—atherosclerosis	0.000528	0.00219	CcSEcCtD
Formoterol—Fatigue—Ezetimibe—atherosclerosis	0.000528	0.00219	CcSEcCtD
Formoterol—Infection—Pravastatin—atherosclerosis	0.000524	0.00218	CcSEcCtD
Formoterol—Constipation—Ezetimibe—atherosclerosis	0.000523	0.00217	CcSEcCtD
Formoterol—Pain—Ezetimibe—atherosclerosis	0.000523	0.00217	CcSEcCtD
Formoterol—Tachycardia—Niacin—atherosclerosis	0.000523	0.00217	CcSEcCtD
Formoterol—Pruritus—Rosuvastatin—atherosclerosis	0.000521	0.00216	CcSEcCtD
Formoterol—Skin disorder—Niacin—atherosclerosis	0.000521	0.00216	CcSEcCtD
Formoterol—Dyspnoea—Simvastatin—atherosclerosis	0.00052	0.00216	CcSEcCtD
Formoterol—Feeling abnormal—Lovastatin—atherosclerosis	0.000514	0.00213	CcSEcCtD
Formoterol—Dyspepsia—Simvastatin—atherosclerosis	0.000514	0.00213	CcSEcCtD
Formoterol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00051	0.00212	CcSEcCtD
Formoterol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000504	0.00209	CcSEcCtD
Formoterol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000504	0.00209	CcSEcCtD
Formoterol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000504	0.00209	CcSEcCtD
Formoterol—Fatigue—Simvastatin—atherosclerosis	0.000503	0.00209	CcSEcCtD
Formoterol—Hypotension—Niacin—atherosclerosis	0.000501	0.00208	CcSEcCtD
Formoterol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000501	0.00208	CcSEcCtD
Formoterol—Constipation—Simvastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Formoterol—Pain—Simvastatin—atherosclerosis	0.000499	0.00207	CcSEcCtD
Formoterol—Urticaria—Lovastatin—atherosclerosis	0.000496	0.00206	CcSEcCtD
Formoterol—Abdominal pain—Lovastatin—atherosclerosis	0.000493	0.00205	CcSEcCtD
Formoterol—Body temperature increased—Lovastatin—atherosclerosis	0.000493	0.00205	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000488	0.00203	CcSEcCtD
Formoterol—Dizziness—Rosuvastatin—atherosclerosis	0.000487	0.00202	CcSEcCtD
Formoterol—Urticaria—Ezetimibe—atherosclerosis	0.000486	0.00202	CcSEcCtD
Formoterol—Insomnia—Niacin—atherosclerosis	0.000485	0.00201	CcSEcCtD
Formoterol—Abdominal pain—Ezetimibe—atherosclerosis	0.000484	0.00201	CcSEcCtD
Formoterol—Body temperature increased—Ezetimibe—atherosclerosis	0.000484	0.00201	CcSEcCtD
Formoterol—Feeling abnormal—Simvastatin—atherosclerosis	0.000481	0.002	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000481	0.002	CcSEcCtD
Formoterol—Dyspnoea—Niacin—atherosclerosis	0.000478	0.00198	CcSEcCtD
Formoterol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Formoterol—Insomnia—Pravastatin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Formoterol—Somnolence—Niacin—atherosclerosis	0.000477	0.00198	CcSEcCtD
Formoterol—Dyspepsia—Niacin—atherosclerosis	0.000472	0.00196	CcSEcCtD
Formoterol—Dyspnoea—Pravastatin—atherosclerosis	0.000471	0.00195	CcSEcCtD
Formoterol—Dyspepsia—Pravastatin—atherosclerosis	0.000465	0.00193	CcSEcCtD
Formoterol—Rash—Rosuvastatin—atherosclerosis	0.000464	0.00193	CcSEcCtD
Formoterol—Dermatitis—Rosuvastatin—atherosclerosis	0.000464	0.00193	CcSEcCtD
Formoterol—Urticaria—Simvastatin—atherosclerosis	0.000464	0.00192	CcSEcCtD
Formoterol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000463	0.00192	CcSEcCtD
Formoterol—Body temperature increased—Simvastatin—atherosclerosis	0.000462	0.00192	CcSEcCtD
Formoterol—Abdominal pain—Simvastatin—atherosclerosis	0.000462	0.00192	CcSEcCtD
Formoterol—Headache—Rosuvastatin—atherosclerosis	0.000461	0.00191	CcSEcCtD
Formoterol—Hypersensitivity—Lovastatin—atherosclerosis	0.00046	0.00191	CcSEcCtD
Formoterol—Pain—Niacin—atherosclerosis	0.000458	0.0019	CcSEcCtD
Formoterol—Fatigue—Pravastatin—atherosclerosis	0.000455	0.00189	CcSEcCtD
Formoterol—Pain—Pravastatin—atherosclerosis	0.000451	0.00187	CcSEcCtD
Formoterol—Constipation—Pravastatin—atherosclerosis	0.000451	0.00187	CcSEcCtD
Formoterol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000451	0.00187	CcSEcCtD
Formoterol—Asthenia—Lovastatin—atherosclerosis	0.000448	0.00186	CcSEcCtD
Formoterol—Pruritus—Lovastatin—atherosclerosis	0.000442	0.00183	CcSEcCtD
Formoterol—Asthenia—Ezetimibe—atherosclerosis	0.000439	0.00182	CcSEcCtD
Formoterol—Gastrointestinal pain—Niacin—atherosclerosis	0.000438	0.00182	CcSEcCtD
Formoterol—Nausea—Rosuvastatin—atherosclerosis	0.000437	0.00182	CcSEcCtD
Formoterol—Feeling abnormal—Pravastatin—atherosclerosis	0.000435	0.0018	CcSEcCtD
Formoterol—Pruritus—Ezetimibe—atherosclerosis	0.000433	0.0018	CcSEcCtD
Formoterol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000432	0.00179	CcSEcCtD
Formoterol—Hypersensitivity—Simvastatin—atherosclerosis	0.00043	0.00178	CcSEcCtD
Formoterol—Diarrhoea—Lovastatin—atherosclerosis	0.000427	0.00177	CcSEcCtD
Formoterol—Urticaria—Niacin—atherosclerosis	0.000426	0.00177	CcSEcCtD
Formoterol—Body temperature increased—Niacin—atherosclerosis	0.000424	0.00176	CcSEcCtD
Formoterol—Abdominal pain—Niacin—atherosclerosis	0.000424	0.00176	CcSEcCtD
Formoterol—Urticaria—Pravastatin—atherosclerosis	0.000419	0.00174	CcSEcCtD
Formoterol—Asthenia—Simvastatin—atherosclerosis	0.000419	0.00174	CcSEcCtD
Formoterol—Diarrhoea—Ezetimibe—atherosclerosis	0.000419	0.00174	CcSEcCtD
Formoterol—Body temperature increased—Pravastatin—atherosclerosis	0.000417	0.00173	CcSEcCtD
Formoterol—Abdominal pain—Pravastatin—atherosclerosis	0.000417	0.00173	CcSEcCtD
Formoterol—Pruritus—Simvastatin—atherosclerosis	0.000413	0.00171	CcSEcCtD
Formoterol—Dizziness—Lovastatin—atherosclerosis	0.000413	0.00171	CcSEcCtD
Formoterol—Dizziness—Ezetimibe—atherosclerosis	0.000405	0.00168	CcSEcCtD
Formoterol—Diarrhoea—Simvastatin—atherosclerosis	0.000399	0.00166	CcSEcCtD
Formoterol—Vomiting—Lovastatin—atherosclerosis	0.000397	0.00165	CcSEcCtD
Formoterol—Hypersensitivity—Niacin—atherosclerosis	0.000395	0.00164	CcSEcCtD
Formoterol—Rash—Lovastatin—atherosclerosis	0.000394	0.00163	CcSEcCtD
Formoterol—Dermatitis—Lovastatin—atherosclerosis	0.000393	0.00163	CcSEcCtD
Formoterol—Headache—Lovastatin—atherosclerosis	0.000391	0.00162	CcSEcCtD
Formoterol—Vomiting—Ezetimibe—atherosclerosis	0.000389	0.00162	CcSEcCtD
Formoterol—Hypersensitivity—Pravastatin—atherosclerosis	0.000389	0.00161	CcSEcCtD
Formoterol—Dizziness—Simvastatin—atherosclerosis	0.000386	0.0016	CcSEcCtD
Formoterol—Rash—Ezetimibe—atherosclerosis	0.000386	0.0016	CcSEcCtD
Formoterol—Dermatitis—Ezetimibe—atherosclerosis	0.000386	0.0016	CcSEcCtD
Formoterol—Asthenia—Niacin—atherosclerosis	0.000385	0.0016	CcSEcCtD
Formoterol—Headache—Ezetimibe—atherosclerosis	0.000384	0.00159	CcSEcCtD
Formoterol—Pruritus—Niacin—atherosclerosis	0.000379	0.00157	CcSEcCtD
Formoterol—Asthenia—Pravastatin—atherosclerosis	0.000379	0.00157	CcSEcCtD
Formoterol—Pruritus—Pravastatin—atherosclerosis	0.000373	0.00155	CcSEcCtD
Formoterol—Vomiting—Simvastatin—atherosclerosis	0.000371	0.00154	CcSEcCtD
Formoterol—Nausea—Lovastatin—atherosclerosis	0.000371	0.00154	CcSEcCtD
Formoterol—Rash—Simvastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Formoterol—Dermatitis—Simvastatin—atherosclerosis	0.000368	0.00153	CcSEcCtD
Formoterol—Diarrhoea—Niacin—atherosclerosis	0.000367	0.00152	CcSEcCtD
Formoterol—Headache—Simvastatin—atherosclerosis	0.000366	0.00152	CcSEcCtD
Formoterol—Nausea—Ezetimibe—atherosclerosis	0.000364	0.00151	CcSEcCtD
Formoterol—Diarrhoea—Pravastatin—atherosclerosis	0.000361	0.0015	CcSEcCtD
Formoterol—Dizziness—Niacin—atherosclerosis	0.000354	0.00147	CcSEcCtD
Formoterol—Dizziness—Pravastatin—atherosclerosis	0.000349	0.00145	CcSEcCtD
Formoterol—Nausea—Simvastatin—atherosclerosis	0.000347	0.00144	CcSEcCtD
Formoterol—Vomiting—Niacin—atherosclerosis	0.000341	0.00141	CcSEcCtD
Formoterol—Rash—Niacin—atherosclerosis	0.000338	0.0014	CcSEcCtD
Formoterol—Dermatitis—Niacin—atherosclerosis	0.000338	0.0014	CcSEcCtD
Formoterol—Headache—Niacin—atherosclerosis	0.000336	0.00139	CcSEcCtD
Formoterol—Vomiting—Pravastatin—atherosclerosis	0.000336	0.00139	CcSEcCtD
Formoterol—Rash—Pravastatin—atherosclerosis	0.000333	0.00138	CcSEcCtD
Formoterol—Dermatitis—Pravastatin—atherosclerosis	0.000332	0.00138	CcSEcCtD
Formoterol—Headache—Pravastatin—atherosclerosis	0.000331	0.00137	CcSEcCtD
Formoterol—Nausea—Niacin—atherosclerosis	0.000318	0.00132	CcSEcCtD
Formoterol—Nausea—Pravastatin—atherosclerosis	0.000314	0.0013	CcSEcCtD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA2—atherosclerosis	2.18e-05	0.000447	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.16e-05	0.000443	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.15e-05	0.000442	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.15e-05	0.000441	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.15e-05	0.000441	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.11e-05	0.000434	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.11e-05	0.000433	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ABCA1—atherosclerosis	2.1e-05	0.000432	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.09e-05	0.00043	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPA—atherosclerosis	2.08e-05	0.000426	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.07e-05	0.000424	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.06e-05	0.000423	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.02e-05	0.000415	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BGN—atherosclerosis	2.01e-05	0.000413	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.01e-05	0.000413	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA2—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX15—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2e-05	0.000411	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2e-05	0.00041	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA5—atherosclerosis	1.99e-05	0.000409	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA2—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.98e-05	0.000407	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	1.98e-05	0.000406	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.98e-05	0.000406	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.96e-05	0.000402	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.96e-05	0.000402	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.93e-05	0.000397	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	1.93e-05	0.000397	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	1.92e-05	0.000394	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000393	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPA—atherosclerosis	1.91e-05	0.000392	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.89e-05	0.000389	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPA—atherosclerosis	1.89e-05	0.000389	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	1.89e-05	0.000388	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	1.88e-05	0.000387	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	1.88e-05	0.000386	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.88e-05	0.000385	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.87e-05	0.000384	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLG—atherosclerosis	1.87e-05	0.000384	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.85e-05	0.00038	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BGN—atherosclerosis	1.85e-05	0.00038	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	1.84e-05	0.000378	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BGN—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLG—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA5—atherosclerosis	1.83e-05	0.000376	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.82e-05	0.000374	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA5—atherosclerosis	1.82e-05	0.000372	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.8e-05	0.00037	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.77e-05	0.000364	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.76e-05	0.000362	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.76e-05	0.000362	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.75e-05	0.000359	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.73e-05	0.000356	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOB—atherosclerosis	1.73e-05	0.000355	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.73e-05	0.000355	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.71e-05	0.000351	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.71e-05	0.00035	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.7e-05	0.00035	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.7e-05	0.000349	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.69e-05	0.000346	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.68e-05	0.000345	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.67e-05	0.000344	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.67e-05	0.000342	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000341	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.65e-05	0.00034	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—LPL—atherosclerosis	1.65e-05	0.000339	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.65e-05	0.000339	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000338	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.64e-05	0.000337	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000336	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LDLR—atherosclerosis	1.63e-05	0.000334	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.63e-05	0.000334	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.62e-05	0.000332	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.62e-05	0.000332	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GPX1—atherosclerosis	1.61e-05	0.000331	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.61e-05	0.000329	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.59e-05	0.000327	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CETP—atherosclerosis	1.59e-05	0.000327	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.58e-05	0.000324	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.58e-05	0.000324	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CD36—atherosclerosis	1.57e-05	0.000322	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.56e-05	0.00032	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.55e-05	0.000317	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.54e-05	0.000315	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.53e-05	0.000313	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.52e-05	0.000313	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.52e-05	0.000311	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.51e-05	0.000311	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.51e-05	0.000309	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.5e-05	0.000309	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000309	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.5e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.5e-05	0.000308	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.5e-05	0.000307	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOC3—atherosclerosis	1.49e-05	0.000307	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.49e-05	0.000306	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.49e-05	0.000305	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LDLR—atherosclerosis	1.49e-05	0.000305	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.48e-05	0.000304	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.46e-05	0.0003	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CETP—atherosclerosis	1.46e-05	0.0003	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARA—atherosclerosis	1.46e-05	0.000299	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.46e-05	0.000299	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CETP—atherosclerosis	1.45e-05	0.000298	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000295	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AGT—atherosclerosis	1.41e-05	0.00029	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.4e-05	0.000288	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.39e-05	0.000285	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—atherosclerosis	1.37e-05	0.000281	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOA1—atherosclerosis	1.37e-05	0.000281	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.35e-05	0.000278	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.35e-05	0.000278	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.35e-05	0.000277	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.32e-05	0.000272	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.32e-05	0.000271	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.31e-05	0.000269	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.3e-05	0.000266	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.28e-05	0.000263	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.26e-05	0.00026	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.25e-05	0.000256	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.25e-05	0.000256	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.24e-05	0.000254	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.22e-05	0.000251	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—atherosclerosis	1.21e-05	0.000247	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.2e-05	0.000245	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.18e-05	0.000243	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—atherosclerosis	1.18e-05	0.000243	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.18e-05	0.000242	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.17e-05	0.00024	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.17e-05	0.00024	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.14e-05	0.000235	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.13e-05	0.000232	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.12e-05	0.00023	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.11e-05	0.000228	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.11e-05	0.000227	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000226	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.09e-05	0.000225	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.09e-05	0.000224	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—atherosclerosis	1.08e-05	0.000222	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.07e-05	0.00022	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOB—atherosclerosis	1.05e-05	0.000216	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.04e-05	0.000213	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—atherosclerosis	1.04e-05	0.000213	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.00021	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.02e-05	0.000209	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.01e-05	0.000208	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPL—atherosclerosis	1.01e-05	0.000207	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—atherosclerosis	1e-05	0.000206	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	9.92e-06	0.000204	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—atherosclerosis	9.82e-06	0.000202	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	9.71e-06	0.000199	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOB—atherosclerosis	9.7e-06	0.000199	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOB—atherosclerosis	9.61e-06	0.000197	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CD36—atherosclerosis	9.56e-06	0.000196	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—atherosclerosis	9.48e-06	0.000195	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.43e-06	0.000194	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—atherosclerosis	9.35e-06	0.000192	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPL—atherosclerosis	9.26e-06	0.00019	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPL—atherosclerosis	9.18e-06	0.000188	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.06e-06	0.000186	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—atherosclerosis	9.03e-06	0.000185	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—atherosclerosis	8.95e-06	0.000184	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARA—atherosclerosis	8.89e-06	0.000182	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	8.8e-06	0.000181	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CD36—atherosclerosis	8.8e-06	0.000181	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CD36—atherosclerosis	8.72e-06	0.000179	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AGT—atherosclerosis	8.61e-06	0.000177	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	8.61e-06	0.000177	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	8.5e-06	0.000175	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—atherosclerosis	8.44e-06	0.000173	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	8.37e-06	0.000172	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—atherosclerosis	8.36e-06	0.000172	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA1—atherosclerosis	8.34e-06	0.000171	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.34e-06	0.000171	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	8.32e-06	0.000171	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.26e-06	0.00017	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	8.19e-06	0.000168	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARA—atherosclerosis	8.18e-06	0.000168	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARA—atherosclerosis	8.11e-06	0.000166	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	7.96e-06	0.000163	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AGT—atherosclerosis	7.92e-06	0.000163	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	7.88e-06	0.000162	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AGT—atherosclerosis	7.85e-06	0.000161	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.79e-06	0.00016	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—atherosclerosis	7.76e-06	0.000159	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	7.74e-06	0.000159	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	7.72e-06	0.000158	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	7.71e-06	0.000158	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—atherosclerosis	7.69e-06	0.000158	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—atherosclerosis	7.69e-06	0.000158	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA1—atherosclerosis	7.67e-06	0.000157	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—atherosclerosis	7.62e-06	0.000156	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.61e-06	0.000156	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA1—atherosclerosis	7.6e-06	0.000156	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	7.57e-06	0.000155	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	7.55e-06	0.000155	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—atherosclerosis	7.35e-06	0.000151	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—atherosclerosis	7.21e-06	0.000148	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	7.15e-06	0.000147	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	7.08e-06	0.000145	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7e-06	0.000144	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.99e-06	0.000144	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.94e-06	0.000142	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.92e-06	0.000142	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	6.76e-06	0.000139	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—atherosclerosis	6.76e-06	0.000139	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—atherosclerosis	6.7e-06	0.000138	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—atherosclerosis	6.63e-06	0.000136	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	6.62e-06	0.000136	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—atherosclerosis	6.61e-06	0.000136	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—atherosclerosis	6.57e-06	0.000135	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	6.56e-06	0.000135	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	6.42e-06	0.000132	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—atherosclerosis	6.32e-06	0.00013	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—atherosclerosis	6.08e-06	0.000125	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—atherosclerosis	6.03e-06	0.000124	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—atherosclerosis	5.81e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.78e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—atherosclerosis	5.76e-06	0.000118	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.32e-06	0.000109	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.27e-06	0.000108	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—atherosclerosis	4.94e-06	0.000101	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.84e-06	9.93e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—atherosclerosis	4.77e-06	9.78e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	4.56e-06	9.36e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.46e-06	9.16e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—atherosclerosis	2.91e-06	5.96e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—atherosclerosis	2.67e-06	5.48e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—atherosclerosis	2.65e-06	5.44e-05	CbGpPWpGaD
